New South Wales, Australia

Wayne Gerrard Reilly


Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 30(Granted Patents)


Location History:

  • Northmead, AU (1999 - 2001)
  • New South Wales, AU (1998 - 2002)

Company Filing History:


Years Active: 1998-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Wayne Gerrard Reilly: Innovator in Therapeutic Compounds

Introduction

Wayne Gerrard Reilly is a notable inventor based in New South Wales, Australia. He has made significant contributions to the field of therapeutic compounds, holding a total of four patents. His work focuses on innovative solutions that enhance the efficacy of therapeutic agents.

Latest Patents

Wayne's latest patents include the development of therapeutic compound-fatty acid conjugates. The first patent provides therapeutic conjugates that consist of a therapeutic compound bound to one to three acyl groups derived from fatty acids. These therapeutic compounds are primarily non-steroidal anti-inflammatory agents that include a carboxylic acid group. The invention also involves the use of tromethamine or ethanolamine derivatives to link the acyl groups to the therapeutic compounds. Another patent details a therapeutic compound from the chlorambucil family conjugated to two or three acyl groups derived from fatty acids, showcasing his innovative approach to enhancing therapeutic efficacy.

Career Highlights

Wayne Gerrard Reilly is affiliated with the Commonwealth Scientific and Industrial Research Organisation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic treatments.

Collaborations

Wayne has collaborated with esteemed colleagues, including Robert George Whittaker and Veronika Judith Bender, contributing to a dynamic research environment that fosters innovation.

Conclusion

Wayne Gerrard Reilly's contributions to the field of therapeutic compounds exemplify his commitment to innovation and research. His patents reflect a deep understanding of the complexities involved in developing effective therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…